Special edition: phase 1 trial of one-shot PCSK9 base editing cuts LDL cholesterol by up to 62% · GPR News

Sources

Special edition: phase 1 trial of one-shot PCSK9 base editing cuts LDL cholesterol by up to 62% · GPR News · GPR News